Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Department of Cardiothoracic Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Age Ageing. 2022 Sep 2;51(9). doi: 10.1093/ageing/afac211.
A significant number of older patients planned for transcatheter aortic valve implantation (TAVI) experience a decline in physical functioning and death, despite a successful procedure.
To systematically review the literature on the association of preprocedural muscle strength and physical performance with functional decline or long-term mortality after TAVI.
We followed the PRISMA guidelines and pre-registered this review at PROSPERO (CRD42020208032). A systematic search was conducted in MEDLINE and EMBASE from inception to 10 December 2021. Studies reporting on the association of preprocedural muscle strength or physical performance with functional decline or long-term (>6 months) mortality after the TAVI procedure were included. For outcomes reported by three or more studies, a meta-analysis was performed.
In total, two studies reporting on functional decline and 29 studies reporting on mortality were included. The association with functional decline was inconclusive. For mortality, meta-analysis showed that low handgrip strength (hazard ratio (HR) 1.80 [95% confidence interval (CI): 1.22-2.63]), lower distance on the 6-minute walk test (HR 1.15 [95% CI: 1.09-1.21] per 50 m decrease), low performance on the timed up and go test (>20 s) (HR 2.77 [95% CI: 1.79-4.30]) and slow gait speed (<0.83 m/s) (HR 2.24 [95% CI: 1.32-3.81]) were associated with higher long-term mortality.
Low muscle strength and physical performance are associated with higher mortality after TAVI, while the association with functional decline stays inconclusive. Future research should focus on interventions to increase muscle strength and physical performance in older cardiac patients.
尽管经导管主动脉瓣置换术(TAVI)手术成功,但仍有相当数量的老年患者在术后出现身体功能下降和死亡。
系统回顾文献,探讨 TAVI 术前肌肉力量和身体表现与术后功能下降或长期死亡率的关系。
我们遵循 PRISMA 指南,并在 PROSPERO(CRD42020208032)上预先注册了这项综述。从开始到 2021 年 12 月 10 日,我们在 MEDLINE 和 EMBASE 中进行了系统搜索。纳入报告 TAVI 术前肌肉力量或身体表现与术后功能下降或长期(>6 个月)死亡率关系的研究。对于报告 3 项或更多研究结果的结局,进行了荟萃分析。
共纳入 2 项报告功能下降的研究和 29 项报告死亡率的研究。与功能下降的关系尚无定论。对于死亡率,荟萃分析显示,握力低(风险比(HR)1.80 [95%置信区间(CI):1.22-2.63])、6 分钟步行测试距离较短(每减少 50m,HR 为 1.15 [95% CI:1.09-1.21])、计时起立行走测试表现不佳(>20 秒,HR 为 2.77 [95% CI:1.79-4.30])和步态速度较慢(<0.83m/s,HR 为 2.24 [95% CI:1.32-3.81])与长期死亡率较高相关。
TAVI 术后肌肉力量和身体表现较低与死亡率较高相关,而与功能下降的关系尚无定论。未来的研究应集中于干预措施,以提高老年心脏患者的肌肉力量和身体表现。